U.S. Begins Rollout of the Johnson and Johnson Single-Dose Coronavirus Vaccine

The pharmaceutical company said it planned to roll out 3.9 million doses to state and local governments based on the size of the local adult population as well as federal distribution sites and select pharmacies. Unlike the vaccines developed by Moderna and Pfizer, which require two doses for full immunization, the J&J vaccines only need one dose, according to the FDA.

“For the last 13 months our physicians, our scientists, our engineers have been working around the clock to make this day possible,” Alex Gorsky, CEO of Johnson & Johnson, said during an appearance on “Good Morning America” on Monday. “We couldn’t be more excited.”

The J&J vaccine does not use the mRNA technology used in the other two approved vaccines, which teach cells to make a protein that prompts an immune response.

Read the source article at abcnews.go.com

    Leave a Review or Comment

    Your email address will not be published. Required fields are marked *

    Back to top button